Insomnia Therapy

Trial Location:
Main Campus, Denver, CO
Principal Investigator:

Jack Edinger, PhD

Trial Sponsor(s):

National Institutes of Health

Trial Objective:

The purpose of this study is to learn more about the effectiveness of first- and second-stage therapies for insomnia among individuals who have insomnia alone or in combination with a coexisting psychiatric disorder.

If you decide to enroll this study your participation will last for 16 months, the following things will happen:

  • Initial screening evaluation visit.
  • Maintain a sleep diary.
  • For those who qualify, 6 to 12 weeks of insomnia treatment. 
  • Undergo sleep study.
  • 4 follow-up visits.

Download the flyer for information on this clinical trial.



Who Can Participate:

Participants must be 21 years of age and older with chronic insomnia which is difficulty falling asleep or staying asleep despite adequate opportunity for sleep.


Active Clinical Trials Closed to Recruitment